Table 3 CRP and WBC means between POD 2 and 4, with respect to patients’ complications status, and their respective clinical significance when present (p < 0.05). The PPV, NPV, Se, and Spe for the CRP thresholds p50 (median) and p25, are also shown
Patients Characteristics | WBC Mean between POD 2 and POD 4 | p-value | CRP Mean between POD 2 and POD 4 | p-value | p50 (cut-off = 106.1) | p25 (cut-off = 56.5) |
|---|---|---|---|---|---|---|
Without Complications | 8.23 | 45,79 | Se: 65.57% | Se: 85.25% | ||
vs | p > 0,05 | p < 0,0001 | Spe: 46.15% | Spe: 46.17% | ||
With Complications | 9.46 | 124,3 | PPV:67.44% | PPV: 78.79% | ||
NPV:66.67% | NPV: 57.14% | |||||
Without Complication | 45,79 | |||||
vs | ||||||
CD 1–2 | N/A | N/A | 80,06 | p < 0,0001 | N/A | N/A |
vs | ||||||
CD 3–4 | 162,4 | |||||
Without Complications | 8.23 | 45,79 | Se: 57.1% | Se: 85.7% | ||
vs | p > 0,05 | p = 0,0004 | Spe: 78.6% | Spe: 53.6% | ||
Infectious Complications | 9.2 | 107,0 | PPV: 76.9% | PPV: 69.8% | ||
NPV: 59.5% | NPV: 75.0% | |||||
Without Complications | 8.23 | 45,79 | Se: 33.3% | Se: 100% | ||
vs | p > 0,05 | p = 0,0163 | Spe: 78.6% | Spe: 53.6% | ||
Non-Infectious Complications | 9.8 | 107,5 | PPV: 14.3% | PPV: 18.8% | ||
NPV: 91.7% | NPV: 100% |